Depo Provera Brain Tumor Lawsuit Overview
Recent scientific studies have found that women who have used Depo-Provera for over 12 months are reportedly at a significantly higher risk of developing these brain tumors, which, though often benign, can lead to severe health complications like seizures, vision loss, and cognitive impairment.
Plaintiffs in Depo Provera Lawsuits allege that Pfizer failed to provide sufficient warnings about these dangers, despite emerging scientific evidence linking Depo-Provera to brain tumor risks.
If you have used the Depo-Provera birth control shot and have developed brain tumors or other serious health complications, you may be eligible to file a Depo Provera Shot Lawsuit.
Contact our Depo-Provera Lawyers for a free consultation.
Use the chatbot on this page for a free case evaluation and to get in touch with a Depo-Provera Attorney today.
Claims Filed by Depo-Provera Patients Over Increased Risk of Brain Tumors
Depo-Provera Lawsuits are being filed by women who developed brain tumors after consistent use of the contraceptive injection.
In February 2025, the Depo-Provera Lawsuit was officially consolidated into multidistrict litigation (MDL) in the US District Court for the Northern District of Florida.
Multidistrict litigation (MDL) is a legal process used to consolidate multiple individual lawsuits that share common issues, such as claims involving the same defective product or harmful drug, into a single federal court for pretrial proceedings.
MDL is not the same as a class action lawsuit, as each case in an MDL remains an individual lawsuit, allowing plaintiffs to seek individualized compensation based on their specific damages.
In contrast, class action lawsuits group all plaintiffs together as a single entity, and any settlement or verdict is distributed equally among the class members.
In an MDL, cases are consolidated only for pretrial proceedings like discovery, but each case may go to trial or settle separately.
This structure allows for more tailored outcomes while streamlining the legal process for similar claims.
Scientific Studies: Depo-Provera Users at Risk of Brain Tumors
Recent scientific research has raised serious concerns about the long-term safety of Depo-Provera, specifically its link to brain tumors.
A pivotal study published in The British Medical Journal (BMJ) in 2024 found that women using Depo-Provera for extended periods are at a significantly higher risk of developing intracranial meningiomas, a type of brain tumor that grows in the protective membranes around the brain and spinal cord.
The study, conducted by French researchers, analyzed data from over 18,000 women who underwent surgery for meningiomas, comparing their cases to control groups without the tumor.
The findings revealed that the use of medroxyprogesterone acetate, the active ingredient in Depo-Provera, was strongly linked to the development of these tumors, especially in long-term users.
This study has brought new attention to the safety risks of Depo-Provera, highlighting the need for further investigation and regulatory updates.
The risks are particularly concerning for women who have used the contraceptive for more than a year, as the study showed a marked increase in tumor development within this group.
Significant findings from the study include:
- 5.6-fold increased risk: Women who used Depo-Provera for 12 months or longer were found to have a 5.6-fold higher risk of developing intracranial meningiomas.
- Meningiomas linked to progestogens: The study confirmed that long-term exposure to progestogens, such as medroxyprogesterone acetate, was a key factor in tumor development.
- Increased tumor size and surgical intervention: Many of the women in the study required surgical intervention due to the tumor’s size and its effect on neurological functions.
- No similar risk in other contraceptives: The study found no significant association between brain tumors and other types of hormonal contraceptives like intrauterine systems (IUDs) containing levonorgestrel.
These findings have intensified scrutiny over Depo-Provera’s safety profile, especially for women using the contraceptive over extended periods, and are central to the ongoing lawsuits against Pfizer.
Does the Depo-Provera Warning Label Include Brain Tumor Risk?
As of 2024, the U.S. warning label for Depo-Provera does not include information about the increased risk of brain tumors, such as intracranial meningiomas.
While regulatory bodies in the European Union and the United Kingdom have updated their labels to reflect this risk, Pfizer has not yet incorporated similar warnings in the United States.
This omission is a central issue in the Depo-Provera Lawsuits being filed against Pfizer, as plaintiffs argue that users were not adequately informed of these dangers.
Information on Intracranial Meningiomas
Intracranial meningiomas are tumors that develop in the meninges, which are the protective membranes surrounding the brain and spinal cord.
These brain tumors are the most common type of primary brain tumor, accounting for about 30% to 40% of all such cases.
While meningiomas are typically benign (non-cancerous), their location in the brain can lead to significant health complications, particularly if they grow large or press against vital brain structures.
The exact cause of meningiomas is not fully understood, but factors such as age, gender, radiation exposure, and genetic mutations can contribute to their development.
As mentioned, patients receiving Depo-Provera injections were at a 5.6x increased risk of developing brain tumors.
Meningiomas grow slowly, and symptoms often appear gradually, depending on the tumor’s size and location.
Common symptoms include severe headaches, seizures, vision changes, and motor difficulties such as weakness or numbness in the limbs.
In some cases, cognitive or personality changes may also occur, particularly if the tumor affects the frontal lobes of the brain.
Meningiomas are classified into three grades:
- Grade I (Benign): The majority of meningiomas fall into this category. These tumors grow slowly and have the lowest risk of recurrence after treatment.
- Grade II (Atypical): These tumors are more aggressive than Grade I meningiomas and have a higher risk of recurrence after treatment.
- Grade III (Malignant): Malignant meningiomas are rare but grow quickly and have a higher chance of spreading and recurring after treatment.
Diagnosis of Intracranial Meningiomas
Diagnosing meningiomas typically involves imaging tests such as MRI (Magnetic Resonance Imaging) or CT (Computed Tomography) scans, which provide detailed images of the brain and can identify the size and location of the tumor.
In some cases, a biopsy may be performed to confirm whether the tumor is benign or malignant.
Treating Intracranial Meningioma Brain Tumors
The treatment of meningiomas depends on several factors, including the size and location of the tumor, the patient’s symptoms, and overall health.
Small, asymptomatic meningiomas may simply be monitored with regular imaging scans (a strategy known as “watchful waiting”).
However, for larger or symptomatic tumors, surgical removal is often recommended.
In some cases, complete removal may not be possible due to the tumor’s location near critical brain structures, in which case partial removal may be followed by radiation therapy to target remaining tumor cells.
- Surgery: Surgery is the most common treatment for meningiomas and aims to remove as much of the tumor as possible. Complete resection offers the best chance of preventing recurrence.
- Radiation Therapy: This treatment may be used after surgery to destroy any remaining tumor cells or as a primary treatment for inoperable meningiomas. Techniques like stereotactic radiosurgery deliver targeted radiation to minimize damage to surrounding tissues.
- Observation: For small, slow-growing meningiomas that do not cause symptoms, regular monitoring may be recommended without immediate treatment.
Prognosis for patients with meningiomas is generally good, particularly for those with benign Grade I tumors.
However, the potential for neurological damage from tumor growth or treatment-related complications can affect long-term outcomes.
Recurrence is possible, especially with atypical or malignant meningiomas, which require ongoing monitoring.
An Overview of How Depo-Provera Works and Why It Is Used
Depo-Provera is a widely used injectable contraceptive that contains medroxyprogesterone acetate, a synthetic version of the hormone progesterone.
It works primarily by preventing ovulation, meaning that the ovaries do not release eggs for fertilization.
Additionally, Depo-Provera works by thickening cervical mucus, which makes it more difficult for sperm to enter the uterus, further reducing the chance of pregnancy.
The hormone also thins the lining of the uterus (endometrium), which helps prevent a fertilized egg from implanting.
Depo-Provera is administered once every three months via an injection from healthcare providers, providing long-term contraception without the need for daily pills or frequent interventions.
Depo-Provera is primarily used as a contraceptive option for women who want a reliable and reversible method of birth control.
Its long-lasting effect makes it an attractive choice for women seeking a low-maintenance form of contraception, especially for those who may have difficulty remembering to take daily pills.
According to the Centers for Disease Control and Prevention (CDC), Depo-Provera is over 99% effective when used correctly.
Apart from contraception, Depo-Provera is also prescribed for other medical reasons, including the management of conditions such as endometriosis and abnormal uterine bleeding.
By thinning the uterine lining, it can help reduce heavy menstrual bleeding, alleviate pain, and lower the risk of endometrial hyperplasia—a condition where the lining of the uterus becomes too thick, increasing the risk of uterine cancer.
However, Depo-Provera use is associated with certain risks and side effects, including bone mineral density loss with long-term use and, more recently, concerns about an increased risk of developing brain tumors such as meningiomas.
These risks make it essential for users to consult with their healthcare providers to weigh the benefits and potential side effects before choosing Depo-Provera as a birth control method or treatment for other conditions.
Do You Qualify for the Depo-Provera Brain Tumor Lawsuit?
Pharmaceutical companies have a responsibility to warn consumers of serious health risks associated with their products, including the potential for brain tumors like intracranial meningiomas linked to Depo-Provera.
These brain tumors can have life-altering effects, causing symptoms such as seizures, vision loss, and cognitive impairment, which can profoundly impact an individual’s daily life and well-being.
Lawyers are currently accepting cases to help individuals who have suffered from these complications pursue compensation for the harm caused by the drug.
If you or a loved one has suffered brain tumors, after using Depo-Provera, you may be entitled to compensation for your medical expenses, pain and suffering, and other damages.
Contact TorHoerman Law today for a free case review to find out if you qualify for legal action.
Use the chat feature on this page to find out if you qualify for the Depo Provera Brain Tumor Lawsuit instantly.
A Depo-Provera Lawyer can help in all aspects of your legal claim, including preliminary steps of gathering evidence and assessing the harm you’ve suffered.
Gathering Evidence for Your Depo-Provera Lawsuit
Strong evidence is critical to proving your claim in a Depo-Provera lawsuit and securing the compensation you deserve.
It establishes the link between your use of the contraceptive and the development of serious health conditions, such as brain tumors.
The more comprehensive and well-documented your evidence, the stronger your case will be, which can increase your chances of a successful outcome.
Possible evidence in a Depo-Provera Brain Tumor Lawsuit may include:
- Medical records: Documentation of your diagnosis, treatment plans, and any imaging tests that confirm the presence of a brain tumor or other health issues.
- Prescription records: Proof of how long and how frequently you used Depo-Provera, including refill dates and dosages.
- Doctor’s notes and expert testimony: Written statements from healthcare providers linking your health issues to Depo-Provera, as well as testimony from medical experts.
- Product packaging and information: Copies of the warning labels, prescription information, and any educational materials provided by the drug manufacturer.
- Personal health journal: Logs of symptoms and how they impacted your daily life, including any changes in health following Depo-Provera use.
- Financial records: Documentation of lost wages, medical bills, and other expenses related to your condition.
Assessing Damages in Depo-Provera Lawsuits
In legal terms, damages refer to the compensation awarded to plaintiffs for the losses they have suffered due to the wrongful actions or negligence of another party.
In the context of Depo-Provera Lawsuits, damages are meant to compensate individuals for the physical, emotional, and financial hardships caused by the drug’s serious side effects, such as brain tumors.
Assessing damages accurately is crucial, as it helps determine the amount of compensation that may be recovered to cover medical expenses, lost wages, pain and suffering, and other losses.
Potential damages in a Depo Provera Brain Tumor Lawsuit may include:
- Medical expenses: Costs associated with diagnosing, treating, and managing health conditions like brain tumors, including surgeries, hospital stays, medications, and ongoing care.
- Lost wages: Compensation for the income lost due to time off work for medical treatment or recovery, as well as diminished earning capacity if you are unable to return to work.
- Pain and suffering: Damages to account for the physical pain and emotional distress caused by serious side effects, such as seizures, headaches, or permanent neurological issues.
- Loss of quality of life: Compensation for the reduced ability to enjoy everyday activities, relationships, and overall well-being due to long-term health complications.
- Disability or permanent impairment: If Depo-Provera-related health issues result in a lasting disability, damages may be awarded to cover the impact on your life and future.
- Punitive damages: In cases where the drug manufacturer’s behavior is found to be particularly negligent or reckless, punitive damages may be awarded to punish the wrongdoing and deter similar actions.
TorHoerman Law: Depo-Provera Lawyers
The serious risks associated with the injectable form of birth control Depo-Provera cannot be understated.
Prolonged use has been linked to severe health complications, including an increased risk of developing intracranial meningiomas, a type of brain tumor.
These tumors, while often benign, can lead to life-altering symptoms such as seizures, vision loss, and cognitive impairment, significantly affecting a person’s quality of life.
If you received a brain tumor diagnosis after consistently taking Depo-Provera shots, you may be eligible to file a Depo Provera Brain Tumor Lawsuit and seek compensation.
Contact the Depo-Provera Lawyers at TorHoerman Law for a free case review.
Use the chatbot on this page for a free case evaluation to find out if you are eligible to file a Depo-Provera Lawsuit instantly.
